Analgesics
Antiandrogens
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lactoferrin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Quercetin
Remdesivir
Vitamins

Other
Feedback
Home
Top
Results
Abstract
All povidone‑iodine studies
Meta analysis
 
Feedback
Home
c19early.org COVID-19 treatment researchPVP-IPovidone-Iod.. (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Viral load, day 5 83% Improvement Relative Risk Viral load, day 5 (b) 86% Viral load, day 3 82% Viral load, day 3 (b) 91% Povidone-Iodine  Karaaltin et al.  EARLY TREATMENT  RCT Is early treatment with povidone-iodine beneficial for COVID-19? RCT 60 patients in Turkey (September - October 2021) Improved viral load with povidone-iodine (p=0.007) c19early.org Karaaltin et al., Authorea, Inc., October 2022 Favors povidone-iodine Favors control

Effect of the povidone iodine, hypertonic alkaline solution and saline nasal lavage on nasopharyngeal viral load in COVID-19

Karaaltin et al., Authorea, Inc., doi:10.22541/au.166675335.56566797/v1
Oct 2022  
  Twitter
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
RCT 120 outpatients in Turkey, showing improved reduction in viral load with PVP-I nasal irrigation.
PVP-I prepared with hypertonic alkaline solution had better results. Kreutzberger show that SARS-CoV-2 requires acidic pH to infect cells, therefore alkalinization may add additional benefits.
All patients received favipiravir. PVP-I 1% 4 times per day.
Targeted administration to the respiratory tract provides treatment directly to the typical source of initial SARS-CoV-2 infection and replication, and allows for rapid onset of action, higher local drug concentration, and reduced systemic side effects.
viral load, 83.1% lower, relative load 0.17, p = 0.007, treatment 30, control 30, relative change in viral load, PVP-I vs. control, day 5.
viral load, 85.5% lower, relative load 0.14, p = 0.001, treatment 30, control 30, relative change in viral load, PVP-I + HANI vs. control, day 5.
viral load, 82.1% lower, relative load 0.18, p = 0.14, treatment 30, control 30, relative change in viral load, PVP-I vs. control, day 3.
viral load, 90.8% lower, relative load 0.09, p < 0.001, treatment 30, control 30, relative change in viral load, PVP-I + HANI vs. control, day 3.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Karaaltin et al., 26 Oct 2022, Randomized Controlled Trial, Turkey, preprint, 16 authors, study period September 2021 - October 2021.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperPovidone-Iod..All
EFFECT OF THE POVIDONE IODINE, HYPERTONIC ALKALINE SOLUTION AND SALINE NASAL LAVAGE ON NASOPHARYNGEAL VIRAL LOAD IN COVID-19
Aysegul Karaaltin, Ozgur Yigit, Dogan Cakan, Özer Akgül, Enes Yiğit, Yetkin Zeki Yılmaz, Kays Burak Çakır, Gamze Çiftçi, Nihal Seden, Abdurrahman Çağlıyan, Efe Can, Özgür Dikme, Yalçın Hacıoğlu, Ilker Inanç Balkan, Özgün Enver, Ahmet Ozdogan
doi:10.22541/au.166675335.56566797/v1
Objective: The causative virus of COVID-19 is SARS-CoV-2. The aim of the present study was to invastigate the in vivo virucidal activity of nasal irrigation with saline, nasal irrigation with Povidone-iodine (PVP-I) 1%, nasal irrigation with hypertonic alkaline and nasal irrigation with PVP-I 1% against SARS CoV-2. Design: The present study was a prospective randomized clinical trial. Setting: A multicenter study involving tertiary care centers. Participants: The study included adult outpatients whose qualitative SARS-CoV-2 RT-PCR tests in nasopharyngeal swabs were positive. One hundred twenty patients divided into four equal groups. Standard COVID-19 treatment was given to group 1 (n=30), nasal irrigation containing isotonic solution was added to patients' treatment in group 2 (n=30), nasal irrigation containing 1% PVP solution was added to patients' treatment in group 3(n=30), and nasal irrigation containing 1% PVP solution and nasal irrigation containing hypertonic alkaline solution was added to patients' treatment in group 4 (n=30). Main outcome measures: On the first day of diagnosis (day 0), nasopharyngeal swab samples were taken, on the 3rd and 5th days the nasopharyngeal viral load reduction in quantitative RT-PCR tests were calculated. Results: Between the 0-3rd Day and 0-5th days, the nasopharyngeal viral load reduction was significant in all groups (p< .05). In paired comparisons of groups, the nasopharyngeal viral load decrease in group 4 in first 3 days was significantly lower than all groups (p < .05). The nasopharyngeal viral load degrease in groups 3 and 4 in the first 5 days were significantly lower than group 1 (p < .05). Conclussion: This study was reveal that the use of hypertonic alkaline nasal irrigation together with 1% povidone-iodine was more effective in reducing viral load in the early period. The decreased nasopharyngeal viral load may reduce the carriage of infectious SARS-CoV-2 in patients. Our results suggest that 1% povidone-iodine and hypertonic alkaline nasal irrigation may be promising modality to prevent the COVID-19 epidemic.
alkaline-solution-and-saline-nasal-lavage-on-nasopharyngeal-viral-load-in-covid-19 Hosted file table 1.docx available at https://authorea.com/users/337860/articles/592062-effect-of-thepovidone-iodine-hypertonic-alkaline-solution-and-saline-nasal-lavage-on-nasopharyngealviral-load-in-covid-19 Hosted file
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit